Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity

被引:51
|
作者
Medana, I
Li, ZX
Flügel, A
Tschopp, J
Wekerle, H
Neumann, H
机构
[1] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany
[2] Univ Lausanne, Inst Biochim, CH-1066 Epalinges, Switzerland
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 167卷 / 02期
关键词
D O I
10.4049/jimmunol.167.2.674
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous work showed that neurons of the CNS are protected against perforin-mediated T cell cytotoxicity, but are susceptible to Fas-mediated apoptosis. In this study, we report that Fas ligand (FasL) expression by neurons is involved in protection against perforin-mediated T cell cytotoxicity. Gene transcripts for FasL were identified in single murine hippocampal neurons by RT-PCR combined with patch clamp electrophysiology, and constitutive expression of FasL protein was confirmed in neurons by immunohistochemistry. Neurons derived from wild-type C57BL/6 (BL6) mice and mutant BL6.gld mice lacking functional FaSL were confronted with allogeneic, CTLs and continuously monitored in real time for changes in levels of intracellular calcium ([Ca2+](i)), an indicator of cytotoxic damage. Perforin-mediated plasma membrane lysis, characterized by rapid, massive [Ca2+](i) influx into the target cells within 0.5 h, was not detected in wild-type neurons. In striking contrast, FasL-deficient neurons showed rapid increase in [Ca2+](i) within 0.5 h, reflecting perforin-dependent cell lysis. FasL seems to protect neurons by blocking degranulation of CTLs, since CD3-induced release of cytotoxic granules was reduced by coapplication of Fas-specific Abs or rFasL.
引用
收藏
页码:674 / 681
页数:8
相关论文
共 50 条
  • [1] Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes
    Lowin, B
    Mattman, C
    Hahne, M
    Tschopp, J
    INTERNATIONAL IMMUNOLOGY, 1996, 8 (01) : 57 - 63
  • [2] IL-2 induces Fas ligand Fas (CD95L/CD95) cytotoxicity in CD8(+) and CD4(+) T lymphocyte clones
    Esser, MT
    Dinglasan, RD
    Krishnamurthy, B
    Gullo, CA
    Graham, MB
    Braciale, VL
    JOURNAL OF IMMUNOLOGY, 1997, 158 (12): : 5612 - 5618
  • [3] Regulation of the proinflammatory effects of Fas ligand (CD95L)
    Chen, JJ
    Sun, YN
    Nabel, GJ
    SCIENCE, 1998, 282 (5394) : 1714 - 1717
  • [4] Tumor expression of Fas ligand (CD95L) and the consequences
    Walker, PR
    Saas, P
    Dietrich, PY
    CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) : 564 - 572
  • [5] Fas Ligand (CD95L) and Cancer Gene Therapy
    Gary J. Nabel
    Nature Biotechnology, 1999, 17 (Suppl 4) : 25 - 25
  • [6] IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity in vivo
    Aung, S
    Graham, BS
    JOURNAL OF IMMUNOLOGY, 2000, 164 (07): : 3487 - 3493
  • [7] Staphylococcal enterotoxin A-induced hepatotoxicity is predominately mediated by Fas ligand (CD95L)
    Klintman, D
    Li, X
    Sato, T
    Wang, YS
    Jeppsson, B
    Thorlacius, H
    ANNALS OF SURGERY, 2004, 240 (06) : 1065 - 1073
  • [8] Cellular localization and function of Fas ligand (CD95L) in tumors
    Kurooka, M
    Nuovo, GJ
    Caligiuri, MA
    Nabel, GJ
    CANCER RESEARCH, 2002, 62 (05) : 1261 - 1265
  • [9] Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L)
    Winter, H
    Hu, HM
    Urba, WJ
    Fox, BA
    JOURNAL OF IMMUNOLOGY, 1999, 163 (08): : 4462 - 4472
  • [10] Elimination of P-berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity
    Renggli, J
    Hahne, M
    Matile, H
    Betschart, B
    Tschopp, J
    Corradin, G
    PARASITE IMMUNOLOGY, 1997, 19 (03) : 145 - 148